Reuters logo
BRIEF-Medtronic announces outcomes from VeClose clinical trial, ‍WAVES study​
2017年4月25日 / 下午3点41分 / 5 个月前

BRIEF-Medtronic announces outcomes from VeClose clinical trial, ‍WAVES study​

April 25 (Reuters) - Medtronic Plc:

* New Medtronic data demonstrate clinical and quality of life benefits for VenaSeal closure system in venous reflux disease patients

* Announced three-year outcomes from VeClose U.S. Pivotal clinical trial and one-year data from waves study

* Patients treated with either VenaSeal or ClosureFast reflected statistically significant improvement from baseline Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below